Skip to main content

Clinical Pharmacokinetics

Ausgabe 4/2014

Inhalt (7 Artikel)

Review Article

Practical Guidelines for Therapeutic Drug Monitoring of Anticancer Tyrosine Kinase Inhibitors: Focus on the Pharmacokinetic Targets

Huixin Yu, Neeltje Steeghs, Cynthia M. Nijenhuis, Jan H. M. Schellens, Jos H. Beijnen, Alwin D. R. Huitema

Original Research Article

Pooled Population Pharmacokinetic Analysis of Phase I, II and III Studies of Linifanib in Cancer Patients

Ahmed Hamed Salem, Denise Koenig, Dawn Carlson

Original Research Article

Integrated Population Pharmacokinetic/Viral Dynamic Modelling of Lopinavir/Ritonavir in HIV-1 Treatment-Naïve Patients

Kun Wang, David Z. D’Argenio, Edward P. Acosta, Anandi N. Sheth, Cecile Delille, Jeffrey L. Lennox, Corenna Kerstner-Wood, Ighovwerha Ofotokun

Original Research Article

Influence of Gestational Age and Body Weight on the Pharmacokinetics of Labetalol in Pregnancy

James H. Fischer, Gloria E. Sarto, Jennifer Hardman, Loraine Endres, Thomas M. Jenkins, Sarah J. Kilpatrick, Hyunyoung Jeong, Stacie Geller, Kelly Deyo, Patricia A. Fischer, Keith A. Rodvold

Original Research Article

Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug

Fabrice Balavoine, Michel Azizi, Damien Bergerot, Nadia De Mota, Rémi Patouret, Bernard P. Roques, Catherine Llorens-Cortes